{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-034944","form_type":"8-K","ticker":"NEOG","cik":"0000711377","company_name":"NEOGEN CORP","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.461326+00:00","generated_at":"2026-06-13T01:19:39.006111+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Neogen Q4 revenue up 72.6% to $241.8M; net income $5.6M; FY2024 guidance issued","bullets":["Q4 revenue $241.8M (+72.6% YoY); net income $5.6M ($0.03 EPS); adjusted net income $30.2M ($0.14 EPS).","Full-year revenue $822.4M (+56%); net loss of $22.9M; adjusted net income $105.7M ($0.56 EPS).","Adjusted EBITDA Q4 $63.1M (26.1% margin); FY $205.4M (25.0% margin).","Food Safety segment Q4 revenue $169.3M (+151.3%), core growth 3.9%; Animal Safety $72.5M (flat).","FY2024 guidance: revenue $955-985M, adjusted EBITDA $235-255M, capex ~$130M (incl. $100M for 3M integration)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-034944","json":"https://secwatch.observer/filing/0000950170-23-034944.json","markdown":"https://secwatch.observer/filing/0000950170-23-034944.md","text":"https://secwatch.observer/filing/0000950170-23-034944.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711377/000095017023034944/0000950170-23-034944-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711377/000095017023034944/neog-20230727.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T01:19:39.006111+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc7760e09db130b4e1bf746e43a518a67a89488e","claim":"NEOGEN CORP reported fiscal 2023 fourth quarter ended May 31, 2023 results: revenue $241.8 million, net income $5.6 million, EPS $0.03 per diluted share.","evidence_excerpt":"Neogen Announces Fourth-Quarter 2023 Results • Revenue of $241.8 million, an increase of 72.6% over the prior-year quarter. • Net income of $5.6 million; $0.03 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711377/000095017023034944/0000950170-23-034944-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2023 fourth quarter ended May 31, 2023"},{"label":"Revenue","value":"$241.8 million"},{"label":"Net income","value":"$5.6 million"},{"label":"EPS","value":"$0.03 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"df65695063e3e07d85b437783f10b942aa407349","claim":"NEOGEN CORP reported fiscal year ended May 31, 2023 results: revenue $822.4 million, net income a loss of $22.9 million, EPS $0.12 per diluted share.","evidence_excerpt":"fourth quarter marked the 124th of the past 130 quarters that Neogen reported revenue increases compared to the same quarter in the prior year. Revenues for the full year were $822.4 million, an increase of 56.0% compared to $527.2 million in the prior year. Core revenue growth was 4.0% and acquisitions contributed 54.5%, while foreign currency was a headwind of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711377/000095017023034944/0000950170-23-034944-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended May 31, 2023"},{"label":"Revenue","value":"$822.4 million"},{"label":"Net income","value":"a loss of $22.9 million"},{"label":"EPS","value":"$0.12 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}